AZD0292
D7700C00003
Phase 2 mab active
Quick answer
AZD0292 for Bronchiectasis With Pseudomonas Aeruginosa Colonization is a Phase 2 program (mab) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Bronchiectasis With Pseudomonas Aeruginosa Colonization
- Phase
- Phase 2
- Modality
- mab
- Status
- active